JAMA Psychiatry Author Interviews
JAMA Network
Interviews with authors of articles from JAMA Psychiatry. JAMA Psychiatry is an international peer-reviewed journal for clinicians, scholars, and research scientists in psychiatry, mental health, behavioral science, and allied fields. JAMA Psychiatry strives to publish original, state-of-the-art studies and commentaries of general interest to clinicians, scholars, and research scientists in the field. The journal seeks to inform and to educate its readers as well as to stimulate debate and further exploration into the nature, causes, treatment, and public health importance of mental illness.
Episodes
Mentioned books
Apr 16, 2014 • 8min
Atypical Cross Talk Between Mentalizing and Mirror Neuron Networks in Autism Spectrum Disorder
Interview with Ralph-Axel Müller, PhD, author of Atypical Cross Talk Between Mentalizing and Mirror Neuron Networks in Autism Spectrum Disorder
Feb 12, 2014 • 5min
Multisystem Component Phenotypes of Bipolar Disorder for Genetic Investigations of Extended Pedigrees
Interview with Carrie E. Bearden, PhD, author of Multisystem Component Phenotypes of Bipolar Disorder for Genetic Investigations of Extended Pedigrees
Dec 4, 2013 • 7min
Increased Hippocampal Glutamate and Volumetric Deficits in Unmedicated Patients With Schizophrenia
Interview with Adrienne C. Lahti, MD, author of Increased Hippocampal Glutamate and Volumetric Deficits in Unmedicated Patients With Schizophrenia
Oct 2, 2013 • 8min
Boundaries of Schizoaffective Disorder: Revisiting Kraepelin
Interview with Roman Kotov, PhD, author of Boundaries of Schizoaffective Disorder: Revisiting Kraepelin
Sep 4, 2013 • 12min
Preventing Depressive Relapse and Recurrence in Higher-Risk Cognitive Therapy Responders: A Randomized Trial of Continuation Phase Cognitive Therapy, Fluoxetine, or Matched Pill Placebo
Interview with Robin B. Jarrett, PhD and Michael E. Thase, MD, authors of Preventing Depressive Relapse and Recurrence in Higher-Risk Cognitive Therapy Responders: A Randomized Trial of Continuation Phase Cognitive Therapy, Fluoxetine, or Matched Pill Placebo
Jul 3, 2013 • 12min
A Prospective Assessment of Reports of Drinking to Self-medicate Mood Symptoms With the Incidence and Persistence of Alcohol Dependence
Interview with Rosa M. Crum, MD, MHS, author of A Prospective Assessment of Reports of Drinking to Self-medicate Mood Symptoms With the Incidence and Persistence of Alcohol Dependence
Jun 12, 2013 • 10min
Toward a Neuroimaging Treatment Selection Biomarker for Major Depressive Disorder
Interview with Helen S. Mayberg, MD, author of Toward a Neuroimaging Treatment Selection Biomarker for Major Depressive Disorder
Apr 3, 2013 • 10min
Globally and Locally Reduced MRI Gray Matter Volumes in Neuroleptic-Naive Men With Schizotypal Personality Disorder: Association with Negative Symptoms
Interview with Robert W. McCarley, MD, author of Globally and Locally Reduced MRI Gray Matter Volumes in Neuroleptic-Naive Men With Schizotypal Personality Disorder: Association with Negative Symptoms
Mar 6, 2013 • 7min
Randomized Multicenter Investigation of Folate Plus Vitamin B12 Supplementation in Schizophrenia
Interview with Donald C. Goff, MD, author of Randomized Multicenter Investigation of Folate Plus Vitamin B12 Supplementation in Schizophrenia
Jan 9, 2013 • 9min
Evidence for Increased Glutamatergic Cortical Facilitation in Children and Adolescents With Major Depressive Disorder
Interview with Paul E. Croarkin, DO, MSCS, author of Evidence for Increased Glutamatergic Cortical Facilitation in Children and Adolescents With Major Depressive Disorder
